ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

DOI: 10.18632/oncotarget.26569

Keywords: glioblastoma, brain tumor initiating cells, ATF4, therapy resistance, receptor-tyrosine-kinase-inhibitor

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text